Welcome to our dedicated page for Adapthealth news (Ticker: AHCO), a resource for investors and traders seeking the latest updates and insights on Adapthealth stock.
AdaptHealth Corp. (NASDAQ: AHCO) is a leading provider of patient-centered, healthcare-at-home solutions across the United States. Operating in 47 states, AdaptHealth offers a comprehensive range of home medical equipment (HME) and services to help patients manage chronic conditions and improve their quality of life in the comfort of their homes.
Founded on the principle that everyone deserves a comfortable and independent life, AdaptHealth's offerings include sleep and respiratory therapy, diabetes management supplies, mobility products, wound care, non-invasive ventilation, and nutritional support. Their clinically-focused services assist patients with daily living activities, supporting approximately 4.1 million patients annually through a network of around 670 locations.
The company's core offerings include sleep therapy equipment (including CPAP and biPAP services) for those with obstructive sleep apnea, medical devices for diabetes management (such as continuous glucose monitors and insulin pumps), and oxygen therapy and related chronic care services. Additionally, AdaptHealth provides specialized HME devices and supplies for wound care, urological, incontinence, ostomy, and nutritional needs.
AdaptHealth is renowned for its extensive partnerships with a diverse network of referral sources, including acute care hospitals, sleep labs, pulmonologists, skilled nursing facilities, and clinics. The company serves beneficiaries of Medicare, Medicaid, and commercial insurance payors, making it a cornerstone in the provision of at-home medical care in the U.S.
Despite facing challenges, AdaptHealth has shown remarkable financial resilience and growth. The company reported a net revenue of $793.3 million for the second quarter of 2023, an increase of 9% compared to the same period in 2022. Their adjusted EBITDA reached $171.0 million, up by 14%, showcasing robust financial health and operational efficiency.
Going forward, AdaptHealth continues to focus on enhancing its service offerings and operational efficiency under new leadership. The recent appointment of Suzanne Foster as Chief Executive Officer marks a significant step in the company’s strategic direction, aimed at furthering its mission to deliver high-quality, patient-centered care.
For more detailed financial results and updates, visit AdaptHealth’s official website.
AdaptHealth Corp. (NASDAQ: AHCO) announced its fourth quarter and full-year 2024 results along with its 2025 outlook. For full-year 2024, the company reported net revenue of $3.26 billion (up 1.9%), net income of $90.4 million (compared to a loss of $678.9 million in 2023), and Adjusted EBITDA of $688.7 million (up 2.7%). Cash flow from operations increased to $541.8 million, with free cash flow of $235.8 million.
Fourth quarter 2024 results showed a slight revenue decrease of 0.2% to $856.6 million, while net income was $50.3 million compared to a loss in Q4 2023. The company reached an agreement to sell certain incontinence assets in its Wellness at Home segment.
For fiscal year 2025, AdaptHealth provided guidance of:
- Net revenue of $3.22 billion to $3.36 billion
- Adjusted EBITDA of $670 million to $710 million
- Free cash flow of $180 million to $220 million
CEO Suzanne Foster highlighted progress on the company's strategic initiatives, including the One Adapt initiative, AI application, increasing clinical relevance, organic growth, and balance sheet strengthening.
AdaptHealth Corp. (NASDAQ: AHCO), a national provider of healthcare-at-home solutions, has scheduled its fourth quarter and full year 2024 financial results announcement for Tuesday, February 25, 2025, before market open. The company will host a conference call at 8:30 a.m. ET for analysts and investors to discuss results and business activities.
Participants can join the call using the following dial-in numbers: (800) 245-3047 (Domestic) or (203) 518-9765 (International), with Conference ID: AHCO4Q24. A webcast replay will be available on AdaptHealth's website under 'Investor Relations' for six months following the live call.
AdaptHealth Corp. (NASDAQ: AHCO) announced the appointment of Russell Schuster as Chief Commercial Officer, effective December 2nd, 2024. Schuster will oversee commercial strategy and revenue generation.
He brings over 25 years of experience, most recently serving as President of Cardinal Health Canada, where he improved performance significantly. His background includes roles in Corporate Development, Business Development, and Strategy at Cardinal Health, as well as positions in Investment Banking and M&A at Lehman Brothers, Barclays Capital, and Republic Services. He began his career as a CPA and Consultant with Ernst & Young.
Suzanne Foster, CEO of AdaptHealth, expressed confidence in Schuster's ability to drive growth and enhance patient care. AdaptHealth provides home medical equipment, medical supplies, and related services, reaching approximately 4.2 million patients annually in all 50 states through 670 locations.
AdaptHealth Corp. (NASDAQ: AHCO) has announced its participation in the BofA Securities Home Care Conference 2024, scheduled for Monday, December 9, 2024. The company will engage in a fireside chat at 1:20pm ET during the virtual event. The webcast will be accessible through AdaptHealth's website under the Investor Relations section.
AdaptHealth is a leading provider of healthcare-at-home solutions, serving approximately 4.2 million patients annually across all 50 states through 670 locations in 47 states. The company specializes in home medical equipment, medical supplies, and related services, including sleep therapy equipment, diabetes care supplies, oxygen therapy, and various medical devices for chronically ill patients.
AdaptHealth Corp. (NASDAQ: AHCO), a national leader in healthcare-at-home solutions, announced its participation in the Stifel 2024 Healthcare Conference in New York on November 19, 2024. The company will engage in a fireside chat at 8:00am ET, with the webcast available on their website.
AdaptHealth provides comprehensive home medical equipment, supplies, and services, serving approximately 4.2 million patients across all 50 states through 670 locations in 47 states. Their offerings include sleep therapy equipment, diabetes medical devices, home medical equipment for post-acute care patients, oxygen therapy services, and supplies for chronic conditions including wound care, urological, and nutritional needs.
AdaptHealth Corp. (NASDAQ: AHCO) reported its Q3 2024 financial results with net revenue of $805.9 million, a slight increase of 0.2% year-over-year. The company posted net income of $22.9 million, compared to a net loss of $454.1 million in Q3 2023. Adjusted EBITDA rose 1.9% to $164.3 million.
Year-to-date cash flow from operations improved to $391.4 million, with free cash flow reaching $162.7 million. The company updated its FY2024 guidance, lowering net revenue expectations to $3.220-3.260 billion and adjusted EBITDA to $655-675 million, while raising free cash flow guidance to $175-195 million.
AdaptHealth Corp. (NASDAQ: AHCO) has appointed Diana Nole to its Board of Directors, effective October 16, 2024. Ms. Nole brings over 18 years of senior leadership experience in the Healthcare AI and Healthcare IT industries. She most recently served as the EVP and General Manager of the Healthcare division of Nuance Communications, a Microsoft Cloud & AI company. Prior to that, she spent five years as CEO of the Healthcare division of Wolters Kluwer.
Dale Wolf, Chairman of the AdaptHealth Board, praised Ms. Nole's extensive leadership experience and expertise in business transformation. Ms. Nole expressed enthusiasm about joining the board, stating she was impressed by the company's leadership team and their execution of their plans.
AdaptHealth Corp. (NASDAQ: AHCO), a leading provider of patient-centered, healthcare-at-home solutions, has announced its schedule for releasing third quarter 2024 financial results. The company will disclose its financial performance before the market opens on Tuesday, November 5, 2024. Following the release, management will host a conference call at 8:30 a.m. ET to discuss the results and business activities with analysts and investors.
Interested parties can participate in the call by dialing (800) 343-4136 for domestic callers or (203) 518-9843 for international callers, using the Conference ID: AHCO3Q24. A webcast registration link is also provided. After the live call, a replay will be available for six months on the company's website under the "Investor Relations" section.
Advantage Healthcare Holdings, a regional leader in Comprehensive Outpatient Rehabilitation Facilities and Sleep Centers, has appointed Dinak (Dino) Nair as its new Chief Executive Officer, effective September 1, 2024. Nair succeeds Ryan Tong and brings over 20 years of business experience, including more than a decade in healthcare leadership roles.
Nair's previous positions include Vice President, General Manager of the Health Systems Operating Division at Labcorp (NYSE: LH), Senior Vice President at Thrive Skilled Pediatric Care, and Vice President of Operations at AdaptHealth. He holds an MBA in Public Accounting from Saint John's University.
Timothy Bovard, Chairperson of Advantage's Board, expressed confidence in Nair's ability to lead the company's growth and improve patient outcomes through personalized care. Nair stated his excitement to join Advantage and collaborate with the team to drive improved patient outcomes and deliver value to customers and stakeholders.
AdaptHealth Corp. (NASDAQ: AHCO), a leading provider of healthcare-at-home solutions, has successfully refinanced its senior secured credit facility. The new facility includes a $650 million Term Loan A and a $300 million revolving line of credit, totaling $950 million. This refinancing brings several benefits:
1. Extended maturity up to September 13, 2029
2. Reduced interest rate compared to the previous facility
3. Decreased undrawn commitment fees due to a smaller revolving credit line
The Term Loan proceeds were used to repay the existing loan due in January 2026, without incurring penalties. The new facility involved 13 lenders, with Regions Bank acting as the Administrative Agent.
FAQ
What is the current stock price of Adapthealth (AHCO)?
What is the market cap of Adapthealth (AHCO)?
What services does AdaptHealth Corp. provide?
Where does AdaptHealth operate?
What is included in AdaptHealth’s sleep therapy services?
How does AdaptHealth assist patients with diabetes?
What recent financial performance has AdaptHealth reported?
Who is the current CEO of AdaptHealth Corp.?
What kind of equipment does AdaptHealth provide for respiratory therapy?
How does AdaptHealth support wound care?
What partnerships does AdaptHealth have?
How can investors get more information about AdaptHealth?
